SIC
KLDO

Salem Investment Counselors’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Salem Investment Counselors’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-125
Closed – – 1162
2022
Q1 		$0 Hold
125
– – ﹤0.01% 1157
2021
Q4 		$0 Hold
125
– – ﹤0.01% 1140
2021
Q3 		$1K Hold
125
– – ﹤0.01% 960
2021
Q2 		$1K Buy
+125
New +$886 ﹤0.01% 888

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Salem Investment Counselors's KLDO Position: Q2 2022 in Review

Salem Investment Counselors sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 125 shares.

Salem Investment Counselors first reported a position in KLDO in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q3 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Salem Investment Counselors reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Salem Investment Counselors sold 125 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022.
  • Salem Investment Counselors first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Salem Investment Counselors's Kaleido Biosciences, Inc. Common Stock position peaked at $1K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Salem Investment Counselors's 13F filing for Q2 2022, filed 17 Aug 2022.